News from NORD

Neuroendocrine Tumor Research Foundation Announces Change of Leadership

Publish date: November 2, 2017

 

After six successful years, Ron Hollander will be stepping down as executive director of the Neuroendocrine Tumor Research Foundation. His successor will be Elyse Gellerman. More.

Recommended Reading

TESS Research Foundation Announces Grant Recipients
MDedge Hematology and Oncology
Vestibular Disorders Association Celebrates Balance Awareness Week
MDedge Hematology and Oncology
Nominate a Colleague or Patient for a NORD Rare Impact Award
MDedge Hematology and Oncology
Orphan Drugs Are Not Driving Up the Cost of Health Care, According to New Study
MDedge Hematology and Oncology
NORD Call for Abstracts Reopened
MDedge Hematology and Oncology
NORD Board Chair to Moderate Social Security Administration Forum
MDedge Hematology and Oncology
NORD Supports Orphan Drug Tax Credit
MDedge Hematology and Oncology
Small Kansas Town Turns Night Into Day for Boy With Rare Disease
MDedge Hematology and Oncology
Adrenal Insufficiency United (AIU) Conference
MDedge Hematology and Oncology
American Partnership for Eosinophilic Disorders (APFED) Pilot Grants
MDedge Hematology and Oncology